StockWatch
·
Pharmaceuticals
Board Meeting30 May 2026, 11:11 pm

Vineet Labs defers Audited Standalone Financial Results

AI Summary

Vineet Laboratories Ltd's board meeting on May 30, 2026, deferred the consideration of the audited standalone financial results for the quarter and financial year ended March 31, 2026, as the Audit Committee did not consider and recommend them. The company will intimate the revised dates for the Audit Committee Meeting and Board Meeting to the Stock Exchange(s) in due course. The trading window, which was closed from April 1, 2026, will remain closed until 48 hours after the declaration of the financial results.

Key Highlights

  • Consideration of Audited Standalone Financial Results deferred.
  • Audit Committee did not consider and recommend the results.
  • Revised meeting dates to be intimated to the Stock Exchange.
  • Trading window remains closed until further notice.